Page last updated: 2024-12-07

2-quinolinecarboxaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Quinolinecarboxaldehyde is a heterocyclic organic compound with the formula C10H7NO. It is a yellow solid that is soluble in organic solvents. 2-Quinolinecarboxaldehyde has been shown to have a variety of biological activities, including antibacterial, antifungal, and anti-inflammatory properties. It has also been investigated as a potential anticancer agent. The compound has been synthesized via a variety of methods, including the oxidation of 2-methylquinoline with selenium dioxide or chromic acid, and the reaction of quinoline with formaldehyde in the presence of a base. Its importance lies in its potential for pharmaceutical applications due to its broad spectrum of biological activities. Research on 2-quinolinecarboxaldehyde focuses on understanding its mechanism of action, optimizing its synthesis and exploring its therapeutic potential in various disease models.'

2-quinolinecarboxaldehyde: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID79619
CHEMBL ID1235569
SCHEMBL ID230838
SCHEMBL ID2956928
MeSH IDM0571852

Synonyms (47)

Synonym
STK727090
BB 0221288
CHEMBL1235569
ai3-52673
einecs 226-804-3
nsc 27026
quinoline-2-carboxaldehyde
nsc27026
2-quinolinecarboxaldehyde
quinaldaldehyde
nsc-27026
inchi=1/c10h7no/c12-7-9-6-5-8-3-1-2-4-10(8)11-9/h1-7
quinoline-2-carbaldehyde
5470-96-2
quinoline,2-carboxaldehyde
2-quinolinecarboxaldehyde, 97%
AKOS005766030
2-formylquinoline
Q0064
EN300-84562
A7950
2-quinolinecarbaldehyde
BBL011760
BCP9000116
AM804030
FT-0603710
SCHEMBL230838
quinolinecarboxaldehyde
quinoline aldehyde
WPYJKGWLDJECQD-UHFFFAOYSA-N
quinoline-2-aldehyde
2-quinoline carboxaldehyde
quinolin-2-carboxaldehyde
quinolin-2-carbaldehyde
SCHEMBL2956928
W-105607
J-650207
STR02188
AC-27356
DTXSID90203169
mfcd00075032
CS-W008168
BCP22877
SY019180
SB10623
Z1079442398
HY-W008168
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID668289Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Discovery of a new antileishmanial hit in 8-nitroquinoline series.
AID668288Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Discovery of a new antileishmanial hit in 8-nitroquinoline series.
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
AID1573603Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM preincubated for 4 hrs followed by NO711 addition and measured after 40 mins by LC-ESI-MS/MS analysis relative to control2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Novel Allosteric Ligands of γ-Aminobutyric Acid Transporter 1 (GAT1) by MS Based Screening of Pseudostatic Hydrazone Libraries.
AID668283Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Discovery of a new antileishmanial hit in 8-nitroquinoline series.
AID668290Selectivity index, ratio of CC50 for mouse J774A1 cells to IC50 for Leishmania donovani MHOM/IN/00/DEVI promastigotes2012European journal of medicinal chemistry, Aug, Volume: 54Discovery of a new antileishmanial hit in 8-nitroquinoline series.
AID1602658Inhibition of mouse GAT-1 assessed as percentage of remaining specific binding of NO711 at 1 uM after 4 hrs by LC-ESI-MS/ms analysis relative to control2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors γ-aminobutyric acid transporter 1.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.98 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index37.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]